A short PNA targeting coxsackievirus B3 5′-nontranslated region prevents virus-induced cytolysis(395 views) Musumeci D, Valente M, Capasso D, Palumbo R, Gorlach M, Schmidtke M, Zell R, Roviello GN, Sapio R, Pedone C, Bucci EM
Keywords: 3c Protease, Coxsackievirus B3, Rhinovirus, Viral Rna, Genomic Rna, Oligonucleotide, Peptide Nucleic Acid, Untranslated Region, Article, Base Pairing, Cell Transport, Chemosensitivity, Complex Formation, Controlled Study, Coxsackie Virus B3, Cytolysis, Drug Design, Drug Purification, Drug Synthesis, Enzyme Degradation, Gene Targeting, Human, Human Cell, Kinetics, Molecular Recognition, Nonhuman, Peptide Analysis, Priority Journal, Protein Stability, Protein Synthesis, Protein Targeting, Regulatory Rna Sequence, Rna Binding, Rna Structure, Thermodynamics, Virus Inhibition, Antiviral Agents, Cell Proliferation, Cultured, Coxsackievirus Infections, Cytopathogenic Effect, Dose-Response Relationship, Enterovirus B, Hela Cells, Microbial Sensitivity Tests, Structure-Activity Relationship, Chemical Synthesis, Chemistry, Pharmacology, Drug Effects, Virology, Genetics,
Affiliations: *** IBB - CNR ***
Instituto di Biostrutture e Bioimmagini, CNR, Via Mezzocannone 16, I-80134 Naples, Italy
Abteilung Molekulare Biophysik and NMR-Spektrikopie, Institut für Molekulare Biotechnologie, D-07741 Jena, Germany
Institut für Virologie und Antivirale Therapie, Friedrich-Schiller-Universität, D-07445 Jena, Germany
Institut f r Virologie und Antivirale Therapie, Friedrich-Schiller-Universit t, D-07445 Jena, Germany
Istituto di Biostrutture e Bioimmagini, CNR, I-80134 Naples, Italy.,
References: Dean, N.M., Functional genomics and target validation approaches using antisense oligonucleotide, technology (2001) Curr. Opin. Biotechnol., 12, pp. 622-62
Gao, W.Y., Han, F.S., Storm, C., Egan, W., Cheng, Y.C., Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology (1992) Mol. Pharmacol., 41, pp. 223-229
Armitage, B.A., The impact of nucleic acid secondary structure on PNA hybridization (2003) Drug Discov. Today, 8, pp. 222-228
Nielsen, P.E., Peptide nucleic acids as therapeutic agents (1999) Curr. Opin. Struct. Biol., 9, pp. 353-357
Rebuffat, A.G., Nawrocki, A.R., Nielsen, P.E., Bernasconi, A.G., Bernal-Mendez, E., Frey, B.M., Frey, F.J., Gene delivery by a steroid-peptide nucleic acid conjugate (2002) FASEB J., 16, pp. 1426-1428
Lewis, M.R., Jia, F., Gallazzi, F., Wang, Y., Zhang, J., Shenoy, N., Lever, S.Z., Hannink, M., Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: Preparation, characterization, and in vitro mRNA binding (2002) Bioconjug. Chem., 13, pp. 1176-1180
Eriksson, M., Nielsen, P.E., Good, L., Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli (2002) J. Biol. Chem., 277, pp. 7144-7147
Svanvik, N., Nygren, J., Westman, G., Kubista, M., Free-probe fluorescence of light-up probes (2001) J. Am. Chem. Soc., 123, pp. 803-809
Friebe, P., Lohmann, V., Krieger, N., Bartenschlager, R., Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication (2001) J. Virol., 75, pp. 12047-12057
Becher, P., Orlich, M., Thiel, H.J., Mutations in the 5′ nontranslated region of bovine viral diarrhea virus result in altered growth characteristics (2000) J. Virol., 74, pp. 7884-7894
Kusov, Y.Y., Gauss-Muller, V., In vitro RNA binding of the hepatitis A virus protienase 3C (HAV 3Cpro) to secondary structure elements within the 5′ terminus of the HAV genome (1997) RNA, 3, pp. 291-302
Kim, K.H., Hemenway, C., The 5′ nontranslated region of potato virus X RNA affects both genomic and subgenomic RNA synthesis (1996) J. Virol., 70, pp. 5533-5540
Basso, J., Dallaire, P., Charest, P.J., Devantier, Y., Laliberte, J.F., Evidence for an internal ribosome entry site within the 5′ non-translated region of turnip mosaic potyvirus RNA (1994) J. Gen. Virol., 75 (PART 11), pp. 3157-3165
Lyons, T., Murray, K.E., Roberts, A.W., Barton, D.J., Poliovirus 5′-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesis (2001) J. Virol., 75, pp. 10696-10708
Richards, O.C., Ehrenfeld, E., Poliovirus RNA replication (1990) Curr. Top. Microbiol. Immunol., 161, pp. 89-119
Wimmer, E., Kuhn, R.J., Pincus, S., Yang, C.F., Toyoda, H., Nicklin, M.D., Takeda, N., Molecular events leading to picornavirus genome replication (1987) J. Cell Sci. Suppl., 7, pp. 251-276
Santti, J., Vainionpaa, R., Hyypia, T., Molecular detection and typing of human picornaviruses (1999) Virus Res., 62, pp. 177-183
Wang, Q.M., Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections (2001) Prog. Drug Res., 52 (SPEC. ISSUE), pp. 229-253
Kong, J.S., Venkatraman, S., Furness, K., Nimkar, S., Shepherd, T.A., Wang, Q.M., Aube, J., Hanzlik, R.P., Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication (1998) J. Med. Chem., 41, pp. 2579-2587
Andino, R., Rieckhof, G.E., Baltimore, D., A functional ribonucleoprotein complex forms around the 5′ end of poliovirus RNA (1990) Cell, 63, pp. 369-380
Zell, R., Sidigi, K., Bucci, E., Stelzner, A., Gorlach, M., Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C (2002) RNA, 8, pp. 188-201
Ohlenschlager, O., Wohnert, J., Bucci, E., Seitz, S., Hafner, S., Ramachandran, R., Zell, R., Gorlach, M., The structure of the stemloop D subdomain of coxsackievirus B3 cloverleaf RNA and its interaction with the proteinase 3C (2004) Structure, 12, pp. 237-248
Hingamp, P., van den Brock, A.E., Stoesser, G., Baker, W., The EMBL nucleotide sequence database. Contributing and accessing data (1999) Mol. Biotechnol., 12, pp. 255-267
Skripkin, E.A., Jacobson, A.B., A two-dimensional model at the nucleotide level for the central hairpin of coliphage Q β RNA (1993) J. Mol. Biol., 233, pp. 245-260
Pace, C.N., Vajdos, F., Fee, L., Grimsley, G., Gray, T., How to measure and predict the molar absorption coefficient of a protein (1995) Protein Sci., 4, pp. 2411-2423
Schmidtke, M., Schnittler, U., Jahn, B., Dahse, H., Stelzner, A., A rapid assay for evaluation of antiviral activity against coxsackievirus B3, influenza virus A, and herpes simplex virus type 1 (2001) J. Virol. Methods, 95, pp. 133-143
Isernia, C., Bucci, E., Leone, M., Zaccaro, L., Di Lello, P., Digilio, G., Esposito, S., Fattorusso, R., NMR structure of the single QALGGH zinc finger domain from the Arabidopsis thaliana SUPERMAN protein (2003) Chem Biochem, 4, pp. 171-180
Sosnick, T.R., Fang, X., Shelton, V.M., Application of circular dichroism to study RNA folding transitions (2000) Meth. Enzymol., 317, pp. 393-409
Koppelhus, U., Nielsen, P.E., Cellular delivery of peptide nucleic acid (PNA) (2003) Adv. Drug Deliv. Rev., 55, pp. 267-280
Filipovska, A., Eccles, M.R., Smith, R.A., Murphy, M.P., Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation (2004) FEBS Lett., 556, pp. 180-186
Sazani, P., Kang, S.H., Mauer, M.A., Wie, C., Dillman, J., Summerton, J., Manoharan, M., Kole, R., Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs (2001) Nucleic Acids Res., 29, pp. 3965-3974
Kole, R., Williams, T., Cohen, L., RNA modulation, repair and remodeling by splice switching oligonucleotides (2004) Acta Biochim Pol., 51, pp. 373-378
Moulton, H., Moulton, J.D., Peptide-assisted delivery of steric-blocking antisense oligomers (2003) Curr. Opin. Mol. Ther., 5, pp. 123-132
Koppelhus, U., Zachar, V., Nielsen, P.E., Liu, X., Eugen-Olsen, J., Ebbesen, P., Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA (1997) Nucleic Acids Res., 25, pp. 2167-2173
Terreux, R., Pairot, S., Cabrol-Bass, D., Patino, N., Condom, R., Interaction of new PNA-based molecules with TAR RNA of HIV-1: Molecular modelling and biological evaluation (2001) J. Mol. Graph., 19, pp. 579-585
Lee, R., Kaushik, N., Modak, M.J., Vinayak, R., Pandey, V.N., Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription (1998) Biochemistry, 37, pp. 900-910
Rozhon, E., Cox, S., Buontempo, P., O'Connell, J., Slater, W., De Martino, J., Schwartz, J., Zhang, A., SCH 38057: A picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating (1993) Antiviral Res., 21, pp. 15-35
Dean, N. M., Functional genomics and target validation approaches using antisense oligonucleotide, technology (2001) Curr. Opin. Biotechnol., 12, pp. 622-62
Gao, W. Y., Han, F. S., Storm, C., Egan, W., Cheng, Y. C., Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology (1992) Mol. Pharmacol., 41, pp. 223-229
Armitage, B. A., The impact of nucleic acid secondary structure on PNA hybridization (2003) Drug Discov. Today, 8, pp. 222-228
Nielsen, P. E., Peptide nucleic acids as therapeutic agents (1999) Curr. Opin. Struct. Biol., 9, pp. 353-357
Rebuffat, A. G., Nawrocki, A. R., Nielsen, P. E., Bernasconi, A. G., Bernal-Mendez, E., Frey, B. M., Frey, F. J., Gene delivery by a steroid-peptide nucleic acid conjugate (2002) FASEB J., 16, pp. 1426-1428
Lewis, M. R., Jia, F., Gallazzi, F., Wang, Y., Zhang, J., Shenoy, N., Lever, S. Z., Hannink, M., Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: Preparation, characterization, and in vitro mRNA binding (2002) Bioconjug. Chem., 13, pp. 1176-1180
Kusov, Y. Y., Gauss-Muller, V., In vitro RNA binding of the hepatitis A virus protienase 3C (HAV 3Cpro) to secondary structure elements within the 5 terminus of the HAV genome (1997) RNA, 3, pp. 291-302
Kim, K. H., Hemenway, C., The 5 nontranslated region of potato virus X RNA affects both genomic and subgenomic RNA synthesis (1996) J. Virol., 70, pp. 5533-5540
Richards, O. C., Ehrenfeld, E., Poliovirus RNA replication (1990) Curr. Top. Microbiol. Immunol., 161, pp. 89-119
Wang, Q. M., Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections (2001) Prog. Drug Res., 52 (SPEC. ISSUE), pp. 229-253
Kong, J. S., Venkatraman, S., Furness, K., Nimkar, S., Shepherd, T. A., Wang, Q. M., Aube, J., Hanzlik, R. P., Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication (1998) J. Med. Chem., 41, pp. 2579-2587
Skripkin, E. A., Jacobson, A. B., A two-dimensional model at the nucleotide level for the central hairpin of coliphage Q RNA (1993) J. Mol. Biol., 233, pp. 245-260
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., Gray, T., How to measure and predict the molar absorption coefficient of a protein (1995) Protein Sci., 4, pp. 2411-2423
Sosnick, T. R., Fang, X., Shelton, V. M., Application of circular dichroism to study RNA folding transitions (2000) Meth. Enzymol., 317, pp. 393-409